Chromatic Full-Field Stimulus Thresholds in Patients with Treatment-Naive Age-Related Macular Degeneration

References

• Abraham P, Yue H, Wilson L. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2. Am J Ophthalmol. 2010;150(3):315–324 e311. doi:10.1016/j.ajo.2010.04.011
   PubMed Web of Science ®Google Scholar
• Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997;81(2):154–162. doi:10.1136/bjo.81.2.154
   PubMed Web of Science ®Google Scholar
• Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol. 2006;142(1):1–9. doi:10.1016/j.ajo.2006.02.037
   PubMed Web of Science ®Google Scholar
• Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143(4):566–583. doi:10.1016/j.ajo.2007.01.028
   PubMed Web of Science ®Google Scholar
• Heier JS, Brown DM, Chong V, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119(12):2537–2548. doi:10.1016/j.ophtha.2012.09.006
   PubMed Web of Science ®Google Scholar
• Kaiser PK, Blodi BA, Shapiro H, Acharya NR, Group MS. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114(10):1868–1875. doi:10.1016/j.ophtha.2007.04.030
   PubMed Web of Science ®Google Scholar
• Ross AH, Donachie PH, Sallam A, et al. Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab? Eye (Lond). 2013;27(1):56–64. doi:10.1038/eye.2012.225
   PubMed Web of Science ®Google Scholar
• Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Exp Eye Res. 2005;80(2):259–272. doi:10.1016/j.exer.2004.09.008
   PubMed Web of Science ®Google Scholar
• Roman AJ, Cideciyan AV, Aleman TS, Jacobson SG. Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials. Physiol Meas. 2007;28(8):N51–N56. doi:10.1088/0967-3334/28/8/N02
   PubMed Web of Science ®Google Scholar
• Collison FT, Fishman GA, McAnany JJ, Zernant J, Allikmets R. Psychophysical measurement of rod and cone thresholds in stargardt disease with full-field stimuli. Retina. 2014;34(9):1888–1895. doi:10.1097/IAE.0000000000000144
   PubMed Web of Science ®Google Scholar
• Dimopoulos IS, Freund PR, Knowles JA, MacDonald IM. The natural history of full-field stimulus threshold decline in choroideremia. Retina. 2018;38(9):1731–1742. doi:10.1097/IAE.0000000000001764
   PubMed Web of Science ®Google Scholar
• Stingl KT, Kuehlewein L, Weisschuh N, et al. Chromatic full-field stimulus threshold and pupillography as functional markers for late-stage, early-onset retinitis pigmentosa caused by CRB1 mutations. Transl Vis Sci Technol. 2019;8(6):45. doi:10.1167/tvst.8.6.45
   PubMed Web of Science ®Google Scholar
• Bowmaker JK, Dartnall HJ. Visual pigments of rods and cones in a human retina. J Physiol. 1980;298:501–511. doi:10.1113/jphysiol.1980.sp013097
   PubMed Web of Science ®Google Scholar
• Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–1444. doi:10.1056/NEJMoa062655
   PubMed Web of Science ®Google Scholar
• Simader C, Ritter M, Bolz M, et al. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. Ophthalmology. 2014;121(6):1237–1245. doi:10.1016/j.ophtha.2013.12.029
   PubMed Web of Science ®Google Scholar
• Malet F, Le Goff M, Colin J, et al. Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol. 2014;92(6):e429–436. doi:10.1111/aos.12174
   PubMed Web of Science ®Google Scholar
• DeCroos FC, Toth CA, Stinnett SS, et al. Optical coherence tomography grading reproducibility during the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2012;119(12):2549–2557. doi:10.1016/j.ophtha.2012.06.040
   PubMed Web of Science ®Google Scholar
• Sayanagi K, Sharma S, Yamamoto T, Kaiser PK. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology. 2009;116(5):947–955. doi:10.1016/j.ophtha.2008.11.002
   PubMed Web of Science ®Google Scholar
• Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121(10):1956–1965. doi:10.1016/j.ophtha.2014.04.020
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Martin DF, Toth CA, et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013;120(9):1860–1870. doi:10.1016/j.ophtha.2013.01.073
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Ying GS, Toth CA, et al. Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2018126:252–260.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37(7):1236–1249.
   PubMed Web of Science ®Google Scholar
• Muthiah MN, Gias C, Chen FK, et al. Cone photoreceptor definition on adaptive optics retinal imaging. Br J Ophthalmol. 2014;98(8):1073–1079. doi:10.1136/bjophthalmol-2013-304615
   PubMed Web of Science ®Google Scholar